Trial Outcomes & Findings for SB3 Battery Life Observational Study (NCT NCT02382705)

NCT ID: NCT02382705

Last Updated: 2019-04-02

Results Overview

rate at which small bowel is completely examined (capsule endoscopy enters cecum)

Recruitment status

COMPLETED

Target enrollment

57 participants

Primary outcome timeframe

0.1 - 12 hours

Results posted on

2019-04-02

Participant Flow

Participant milestones

Participant milestones
Measure
PillCam SB3EX
All participants in the study used the PillCam SB3EX for their capsule endoscopy
Overall Study
STARTED
57
Overall Study
COMPLETED
33
Overall Study
NOT COMPLETED
24

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PillCam SB3EX
n=57 Participants
All participants in the study used the PillCam SB3EX for their capsule endoscopy
Age, Categorical
<=18 years
0 Participants
n=57 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
n=57 Participants
Age, Categorical
>=65 years
15 Participants
n=57 Participants
Age, Continuous
53.6 years
STANDARD_DEVIATION 15.7 • n=57 Participants
Sex: Female, Male
Female
28 Participants
n=57 Participants
Sex: Female, Male
Male
29 Participants
n=57 Participants
Region of Enrollment
Canada
57 participants
n=57 Participants

PRIMARY outcome

Timeframe: 0.1 - 12 hours

rate at which small bowel is completely examined (capsule endoscopy enters cecum)

Outcome measures

Outcome measures
Measure
PillCam SB3EX
n=57 Participants
Completion Rate (Rate at Which Small Bowel is Completely Examined)
57 Participants

SECONDARY outcome

Timeframe: 0.1 - 12 hours

rate at which a pathological finding is identified on capsule endoscopy

Outcome measures

Outcome measures
Measure
PillCam SB3EX
n=57 Participants
Diagnostic Yield
20 Participants

SECONDARY outcome

Timeframe: 0.1 - 12 hours

time it takes for capsule camera to traverse the stomach

Outcome measures

Outcome measures
Measure
PillCam SB3EX
n=33 Participants
Gastric Transit Time
37.6 minutes
Standard Deviation 92.1

SECONDARY outcome

Timeframe: 0.1 - 12 hours

times it takes for capsule camera to traverse the entire small bowel.

Outcome measures

Outcome measures
Measure
PillCam SB3EX
n=33 Participants
Small Bowel Transit Time
232.1 minutes
Standard Deviation 98.3

Adverse Events

PillCam SB3EX

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Robert Enns

University of British Columbia

Phone: 604 688 6332

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place